Everyone with cystic fibrosis aged five and over is eligible for COVID-19 vaccination. Some people with cystic fibrosis are also eligible for booster vaccines.
Here you can find information about COVID-19 vaccination for children and adults with cystic fibrosis and for parents/carers.
For information about COVID-19 treatments, please click here.
COVID-19 vaccination for children with cystic fibrosis
All children aged 5 and over in the UK are being offered the COVID-19 vaccine. Children who are in a clinical risk group, which includes children with cystic fibrosis, receive two doses of the vaccine. These are given eight weeks apart.
Children with cystic fibrosis aged 12-15, and all 16-17-year-olds, are also eligible for booster vaccinations. These should be offered at least three months after their second vaccine dose.
You can find further information on COVID-19 vaccination for children in clinical risk groups here.
Please speak to your child’s CF team if you have any questions regarding vaccination.
COVID-19 vaccination for adults with cystic fibrosis
People with cystic fibrosis aged 18 and over should be offered a booster vaccine after they have had their primary vaccine doses. This should be offered at least three months after their second primary dose.
The NHS will let you know when it's your turn to have a booster dose. Most people will be invited to book an appointment at a larger vaccination centre, pharmacy, or local NHS service such as a GP surgery.
I am immunosuppressed but have heard that the vaccine may not be as effective. Should I have a booster vaccine when offered?
Yes. There is some evidence that a third dose of vaccine boosts the level of protection in those who did not appear to respond or responded less strongly to two doses. We wrote to the JCVI (the expert body advising the Government on UK vaccination policy) in June about this study and are pleased that those who are immunocompromised, including people post-transplant and those who live with them, have been offered a third dose of vaccine from autumn 2021.
People who are immunosuppressed, who have had three primary doses of the vaccine, are also being offered a booster dose. This should be given at least three months after the third vaccine dose.
As of February 2022, the JCVI is also recommending a second booster dose for people aged 12 and over who are immunosuppressed (this is being described as a ‘spring booster’). This should be given no sooner than six months from when the last vaccine was given. Further details will be shared when available.
What is the difference between the booster vaccine and the third dose?
The booster vaccine is an additional dose of the vaccine for all those who received two doses as part of the first phase of the vaccine programme. Most people with CF are likely to have had a good immune response to their first two doses. The booster is intended to protect people against COVID-19 infection for longer. All adults will now be offered a booster vaccine at least three months after their course of primary doses.
The third dose is an extra dose of the vaccine for anyone who may not have developed a full immune response from their first two vaccine doses. This is usually people who are immunosuppressed, including people who have had a transplant. The third dose is intended to generate a stronger immune response, and can be given eight weeks after the second vaccination. The exact timing may vary and advice on third vaccines for people who are immunosuppressed should be sought from specialist CF teams or transplant teams.
People who are severely immunosuppressed, who have had three primary doses of the vaccine, are also being offered a booster dose. This should be given at least three months after the third vaccine dose. A second booster to be given no sooner than six months after the first booster, has also now been recommended by the JCVI to boost immunity in the Spring.
If you have any questions about your COVID-19 vaccines, please speak to your CF team.